Stay updated on Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial

Sign up to get notified when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The new screenshot shows a layout change (header/navigation/spacing) with no changes to the actual study details or criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:21:13.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    6%
    Check dated 2025-10-05T10:29:11.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.2%
    Check dated 2025-09-28T03:23:08.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No substantive changes to pricing, stock, or core content.
    Difference
    0.4%
    Check dated 2025-09-13T17:41:35.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.4%
    Check dated 2025-09-06T15:24:15.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as the introduction of new drug names, sintilimab and surufatinib. The revision number has also been updated to v3.0.0.
    Difference
    2%
    Check dated 2025-08-30T12:10:11.000Z thumbnail image

Stay in the know with updates to Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.